In PCa, MAGE-A2 is the most highly upregulated CTA (> 800-fold) that causes the proliferation of cancer cells and decreases chemosensitivity [12]; therefore, it may serve as a perfect antigen that potentially could be used for PCa immunotherapy. The gene discussed is MAGEA2; the disease is posterior cortical atrophy.